Keyphrases
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Cancer Mortality
100%
Glomerulonephritis
100%
Cancer Incidence
100%
Renin-angiotensin-aldosterone System
100%
Cancer Risk
33%
Renal Biopsy
33%
Low Dose Rate
16%
All-cause Mortality
16%
Angiotensin II Type 1 Receptor Blocker
16%
Incidence Rate
16%
Proportional Analysis
16%
Medicine and Dentistry
Malignant Neoplasm
100%
ACE Inhibitor
100%
Cancer Mortality
100%
Aldosterone
100%
Patient with Glomerulonephritis
100%
Cancer Incidence
33%
Renal Biopsy
33%
Angiotensin 1 Receptor Antagonist
16%
Proportional Hazards Model
16%
All Cause Mortality
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Aldosterone
100%
Cancer Mortality
100%
Glomerulonephritis
100%
Cancer Incidence
33%
Angiotensin 1 Receptor Antagonist
16%
All Cause Mortality
16%